Literature DB >> 21945805

Phosphorylation of podocalyxin (Ser415) Prevents RhoA and ezrin activation and disrupts its interaction with the actin cytoskeleton.

Hirotaka Fukasawa1, Hiroaki Obayashi, Sandra Schmieder, Jaesung Lee, Pradipta Ghosh, Marilyn G Farquhar.   

Abstract

Podocalyxin (PC) is a polysialylated, anti-adhesin that is essential for maintaining foot process architecture and the integrity of the glomerular filtration barrier. We showed previously that PC is firmly attached to the actin cytoskeleton through ezrin, that in puromycin aminonucleoside (PAN)-mediated nephrosis the PC-ezrin-actin complex is disrupted, and that PC is uncoupled from actin. However, the precise mechanisms involved remained unknown. Here we show that detachment of PC from actin is regulated by phosphorylation of PC. PC is hyperphosphorylated at serines in PAN- and protamine sulfate (PS)-treated rat glomeruli. We determined that PC is a substrate of PKC and that the site of phosphorylation is Ser415, located within the juxtamembrane, ezrin-binding domain of the cytoplasmic tail of PC. Mutation of Ser415 to the phosphomimetic residues Glu (S415E) or Asp (S415D) interfered with direct binding of the PC cytoplasmic tail to ezrin in vitro. Moreover, stable expression of a phosphomimetic (S415E) PC mutant but not the WT or the phosphorylation-deficient (S415A) PC mutant, disrupted PC-ezrin-actin interaction, failed to activate RhoA, and the cytoskeletal linker, ezrin, remained inactive. Our data indicate that phosphorylation of PC at Ser415 prevents attachment of PC and ezrin to actin and highlights the strategic position of Ser415 and direct binding of PC to ezrin in regulating podocyte foot process architecture.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945805      PMCID: PMC3204015          DOI: 10.1016/j.ajpath.2011.07.046

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin.

Authors:  Robert A Orlando; Tetsuro Takeda; Beverly Zak; Sandra Schmieder; Vivian M Benoit; Tammie McQuistan; Heinz Furthmayr; Marilyn G Farquhar
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

2.  Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein.

Authors:  K Takahashi; T Sasaki; A Mammoto; K Takaishi; T Kameyama; S Tsukita; Y Takai
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

3.  A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility.

Authors:  James W Legg; Charlotte A Lewis; Maddy Parsons; Tony Ng; Clare M Isacke
Journal:  Nat Cell Biol       Date:  2002-06       Impact factor: 28.824

4.  Crystallization and preliminary crystallographic studies of RhoGDI in complex with the radixin FERM domain.

Authors:  K Hamada; A Seto; T Shimizu; T Matsui; Y Takai; S Tsukita; S Tsukita; T Hakoshima
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-05-25

5.  Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases.

Authors:  T Matsui; S Yonemura; S Tsukita; S Tsukita
Journal:  Curr Biol       Date:  1999-11-04       Impact factor: 10.834

6.  Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton.

Authors:  T Takeda; T McQuistan; R A Orlando; M G Farquhar
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

7.  Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells.

Authors:  T Takeda; W Y Go; R A Orlando; M G Farquhar
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

8.  A structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor, c-Mpl.

Authors:  Y Miyakawa; J G Drachman; B Gallis; A Kaushansky; K Kaushansky
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

9.  Functional mapping of the cytoplasmic region of intercellular adhesion molecule-3 reveals important roles for serine residues.

Authors:  J S Hayflick; J Stine; R Fox; D Hoekstra; W M Gallatin
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 10.  ERM-Merlin and EBP50 protein families in plasma membrane organization and function.

Authors:  A Bretscher; D Chambers; R Nguyen; D Reczek
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

View more
  13 in total

Review 1.  Ezrin Orchestrates Signal Transduction in Airway Cells.

Authors:  Lei-Miao Yin; Ting-Ting Duan; Luis Ulloa; Yong-Qing Yang
Journal:  Rev Physiol Biochem Pharmacol       Date:  2018       Impact factor: 5.545

2.  Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.

Authors:  Ping Fu; Zhiyong Yang; Leon A Bach
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

3.  A molecular switch for the orientation of epithelial cell polarization.

Authors:  David M Bryant; Julie Roignot; Anirban Datta; Arend W Overeem; Minji Kim; Wei Yu; Xiao Peng; Dennis J Eastburn; Andrew J Ewald; Zena Werb; Keith E Mostov
Journal:  Dev Cell       Date:  2014-10-09       Impact factor: 12.270

4.  GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis.

Authors:  Inmaculada Lopez-Sanchez; Ying Dunkel; Yoon-Seok Roh; Yash Mittal; Samuele De Minicis; Andrea Muranyi; Shalini Singh; Kandavel Shanmugam; Nakon Aroonsakool; Fiona Murray; Samuel B Ho; Ekihiro Seki; David A Brenner; Pradipta Ghosh
Journal:  Nat Commun       Date:  2014-07-21       Impact factor: 14.919

Review 5.  Podocytes.

Authors:  Jochen Reiser; Mehmet M Altintas
Journal:  F1000Res       Date:  2016-01-28

6.  Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:  Hidenori Kusumoto; Yasushi Shintani; Ryu Kanzaki; Tomohiro Kawamura; Soichiro Funaki; Masato Minami; Izumi Nagatomo; Eiichi Morii; Meinoshin Okumura
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

7.  Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis.

Authors:  Moumita Barua; Eric Shieh; Johannes Schlondorff; Giulio Genovese; Bernard S Kaplan; Martin R Pollak
Journal:  Kidney Int       Date:  2013-09-18       Impact factor: 10.612

8.  The cell surface mucin podocalyxin regulates collective breast tumor budding.

Authors:  Marcia L Graves; Jane A Cipollone; Pamela Austin; Erin M Bell; Julie S Nielsen; C Blake Gilks; Kelly M McNagny; Calvin D Roskelley
Journal:  Breast Cancer Res       Date:  2016-01-22       Impact factor: 6.466

9.  Loss of podocalyxin causes a novel syndromic type of congenital nephrotic syndrome.

Authors:  Hee Gyung Kang; Moses Lee; Kyoung Boon Lee; Michael Hughes; Bo Sang Kwon; Sangmoon Lee; Kelly M McNagny; Yo Han Ahn; Jung Min Ko; Il-Soo Ha; Murim Choi; Hae Il Cheong
Journal:  Exp Mol Med       Date:  2017-12-15       Impact factor: 8.718

10.  Loss of ezrin expression reduced the susceptibility to the glomerular injury in mice.

Authors:  Ryo Hatano; Ai Takeda; Yukiko Abe; Kotoku Kawaguchi; Itsuro Kazama; Mitsunobu Matsubara; Shinji Asano
Journal:  Sci Rep       Date:  2018-03-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.